Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| Molecular target | PPAR delta (NR1C2) | Ligand-activated nuclear receptor. |
| Primary tissues studied | Skeletal muscle, liver, adipose | Effects on fatty acid oxidation and energy use. |
| Typical detection matrix | Urine | Used in anti-doping analysis. |
| Common analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Sport regulatory class | Prohibited at all times | Listed as a metabolic modulator by WADA. |
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
The hospital specialized in the treatment of heart, lung and eye problems. UCC also provided a $2.2 million grant to Arizona State University to establish a vocational-technical centre in Bhopal, which was opened, but was later closed by the state government. They also donated $5 million to the Indian Red Cross after the disaster. They also developed a Responsible Care system with other members of the chemical industry as a response to the Bhopal crisis, which was designed to help prevent such an event in the future.
==== Absorption ==== With oral administration of a single dose, THC is almost completely absorbed by the gastrointestinal tract. However, due to first-pass metabolism in the liver and the high lipid solubility of THC, only about 5 to 20% reaches circulation. Following oral administration, concentrations of THC and its major active metabolite 11-hydroxy-THC (11-OH-THC) peak after 0.5 to 4 hours, with median time to peak of 1.0 to 2.5 hours at different doses. In some cases, peak levels may not occur for as long as 6 hours. Concentrations of THC and 11-hydroxy-THC in the circulation are approximately equal with oral administration. There is a slight increase in dose proportionality in terms of peak and area-under-the-curve levels of THC with increasing oral doses over a range of 2.5 to 10 mg. A high-fat meal delays time to peak concentrations of oral THC by 4 hours on average and increases area-under-the-curve exposure by 2.9-fold, but peak concentrations are not significantly altered. A high-fat meal additionally increases absorption of THC via the lymphatic system and allows it to bypass first-pass metabolism. Consequently, a high-fat meal increases levels of 11-hydroxy-THC by only 25% and most of the increase in bioavailability is due to increased levels of THC. The bioavailability of THC when smoking or inhaling is approximately 25%, with a range of 2% to 56% (although most commonly between 10–35%).
According to experts in the field, 70% of all chemical reactions could be done in microreactors; however, only 10-15% are economically justified. With the exception of some stereospecific reactions, particularly biotechnology, mastering these technologies does not represent a distinct competitive advantage. Most reactions can be carried out in standard multipurpose plants. Reaction-specific equipment, such as ozone or phosgene generators, is readily available. The installation is not generally a critical path on the overall project for developing an industrial-scale process of a new molecule. Whereas the overall demand for outsourced pharmaceutical fine chemicals is expected to increase moderately, the estimated annual growth rates for the above-mentioned niche technologies are much higher. Microreactors, and the SMB separation technology, are expected to grow at a rate of 50–100% per year. The total size of the accessible market typically does not exceed a few hundred tons per year at best.
Trans-sphincteric route into the IAS, Inter-sphincteric route into the IAS, Inter-sphincteric route into the submucosa, Trans-anal injection into the submucosa (similar to injection sclerotherapy for haemorrhoids), Trans-sphincteric route into the inter-sphincteric space, Inter-sphincteric route into the inter-sphincteric space, Trans-sphincteric route injecting submucosally. The perianal injection route (intersphincteric or transsphincteric) gives better results than the transanal route according to one review. Submucosal implant location may have a higher risk of erosion and sepsis.
The news reportedly left palaeontologist John Ostrom, who in the 1970s had pioneered the theory that birds evolved from dinosaurs, "in a state of shock." Ostrom later joined an international team of researchers who gathered in Beijing to examine the fossils; other team members included feather expert Alan Brush, fossil bird expert Larry Martin, and Peter Wellnhofer, an expert on the early bird Archaeopteryx. Three specimens have been assigned to Sinosauropteryx prima: the holotype GMV 2123 (and its counter slab [opposite face], NIGP 127586), NIGP 127587, and D 2141. Another specimen, IVPP V14202, was originally assigned to the genus in 2010, but was later designated as the holotype of a separate genus Huadanosaurus. The assignment of an additional larger specimen to S. prima, GMV 2124 (also known as NGMC 2124), was later found to be in error, and most likely belongs to Tyrannosauroidea. All of the fossils were found in the Jianshangou or Dawangzhangzi Beds of the Yixian Formation in the Beipiao and Lingyuan regions of Liaoning, China. These fossil beds have been dated to 124.6–122 million years ago, during the early Aptian stage of the Early Cretaceous.
Sources: en.wikipedia.org
== Related proteins == Fibronectin The second most abundant ECM molecule, this molecule also promotes homeostasis and maintaining the structure of the collagen matrix, as well as adhesion of cells to the matrix, and is created by hepatocytes. Some key differences include that fibronectin does not need a cartilage proteoglycan monomer to function efficiently, and is found at concentrations ten times higher than chondronectin in plasma. Also, instead of interacting with chondrocytes and type II collagen, fibronectins interact with other cells with types I and III collagen. Another difference is that fibronectin binds to the collagen directly before a cell can interact with the ECM. Laminin These glycoproteins also have a large molecular weight and are also trimeric in structure, like chondronectins. although they have 14 different combinations of trimer structures. Laminins facilitate the attachment of basement membranes in the human body, which are extracellular matrices that hold tissues and cells together. Laminins help to regulate cell activity, and have eleven distinct forms. Type II collagen A structural protein in the collagen matrix, type II collagen is much more abundant in the matrix than chondronectins, as this protein makes up 90-95% of the matrix. It is also found in the vitreous humor, and other areas of hyaline cartilage as well. Some key differences are that type II collagen is a structural protein that helps to provide structure and strength to the matrix, while chondronectins only facilitates binding of type II collagen to chondrocytes.
Microsoft's acquisition of Bethesda Softworks in 2021 was seen as providing several potential killer app games for the Xbox Series X/S, notably Starfield from Bethesda Game Studios, which in addition to launching as a console exclusive in 2023, became a significantly focused game in Xbox's advertising of the consoles in addition to replacing prior tentpole exclusive Halo Infinite (2021) as the key visual game featured on the packaging of Xbox Series X. Ratchet & Clank: Rift Apart was seen as a killer app for the PlayStation 5 due to being a game released at a point in the console's lifecycle where much of the first-party software from Sony was also supplemented by a simultaneous release on PlayStation 4, in addition to being highlighted for its graphical fidelity and use of the console's various hardware features such as faster loading and the functions of the DualSense controller. Mario Kart World and Donkey Kong Bananza are seen as and were positioned by Nintendo as killer apps for the launch window of Nintendo Switch 2, both for their technical improvements over previous entries in their respective series, and for gameplay innovations such as World's open "Free Roam" mode and Bananza's destructible sandbox environments that leverage the increase in hardware potency. Pokémon games are killer apps for Nintendo handhelds, often topping the best-selling charts for whatever system they appear on.
Georgia joined the Iraq war as part of the United States-led coalition in August 2003. By 2008, Georgia had deployed 2,300 troops in Iraq, becoming the third largest contributor to the coalition forces in the Iraq War. In addition, the country provided a battalion of approximately 550 troops to the United Nations Assistance Mission in Iraq. All Georgian troops were withdrawn from Iraq amid the Russia–Georgia war in August 2008. Georgia suffered five fatal casualties in Iraq.
The military occupation of Czechoslovakia by Nazi Germany began with the German annexation of the Sudetenland in 1938, continued with the creation of the Protectorate of Bohemia and Moravia, and by the end of 1944 extended to all parts of Czechoslovakia. Following the Anschluss of Austria in March 1938 and the Munich Agreement in September of that same year, Adolf Hitler annexed the Sudetenland from Czechoslovakia on 1 October, giving Germany control of the extensive Czechoslovak border fortifications in this area. The incorporation of the Sudetenland into Germany left the rest of Czechoslovakia ("Rest-Tschechei" ) with a largely indefensible northwestern border. Also a Polish-majority borderland region of Trans-Olza which was annexed by Czechoslovakia in 1919, was occupied and annexed by Poland following the two-decade long territorial dispute. Finally the First Vienna Award gave to Hungary the southern territories of Slovakia and Carpathian Ruthenia, mostly inhabited by Hungarians. On 14 March 1939, the Slovak parliament voted unanimously to establish an independent Slovak state and German troops preemptively marched into Ostrava to prevent the Poles from occupying the region. The following day, during a visit to Berlin, the Czechoslovak president Emil Hácha was coerced into signing away his country's independence as Hungary annexed the remainder of Carpathian Ruthenia. On 16 March, Hitler proclaimed the Protectorate of Bohemia and Moravia from Prague Castle, leaving Hácha as the nominal, but almost powerless, State President.
Sources: en.wikipedia.org
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.
Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.
Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.